Additional references

w1 Henderson FW, Clyde WA, Collier AM, Denny FW, Senior RJ, Sheaffer CI, et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 1979;95:183-90.

w2 Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28.

w3 Vincente D, Cilla G, Montes M, Perez-Trallero E. Human metapneumovirus and community-acquired respiratory illness in children. Emerg Infect Dis 2003;9:602-3.

w4 Jartti T, van den HB, Garofalo RP, Osterhaus AD, Ruuskanen O. Metapneumovirus and acute wheezing in children. Lancet 2002;360:1393-4.

w5 Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.

w6 Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 1999;26:189-95.

w7 Hietala J, Uhari M, Tuokko H, Leinonen M. Mixed bacterial and viral infections are common in children. Pediatr Infect Dis J 1989;8:683-6.

w8 Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med 2002;156:322-4.

w9 Brooks AM, McBride JT, McConnochie KM, Aviram M, Long C, Hall CB. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics 1999;104:463-7.

w10 Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993;23:50-79.

w11 Condon VR. Pneumonia in children. J Thorac Imaging 1991;6:31-44.

w12 Bont L, van Aalderen WMC, Versteegh J, Brus F, Draaisma JT, Pekelharing-Berghuis M, et al. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing. Pediatr Infect Dis J 2001;20:277-82.

w13 Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, et al. Respiratory syncytial virus infection in children with compromised immune function. N Engl J Med 1986;315:77-81.

w14 Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalised with respiratory syncytial virus. Eur J Pediatr 1998;157:215-20.

w15 Gadomski AM, Lichenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994;93:907-12.

w16 Abul-Ainine A, Luyt D. Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Arch Dis Child 2002;86:276-9.

w17 Dobson JV, Stephens-Groff SM, McMahon SR, Stemmler MM, Brallier SL, Bay C. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics 1998;101:361-8.

w18 Flores G, Horwitz RI. Efficacy of beta-2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100:233-9.

w19 Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Bronchodilator therapy in bronchiolitis. Issue 4. 1998. Oxford: Update Software, The Cochrane Library.[Q to A: Use most recent version?]

w20 Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348:292-5.

w21 Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 patients. Pediatrics 1999;104:e77.

w22 Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr 1997;130:191-6.

w23 Garrison MM, Christiakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 2000;105:e44.

w24 Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002;110:e9.

w25 Rodriguez WJ, Hall CB, Welliver R, Simoes EA, Ryan ME, Stutman H, et al. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. J Pediatr 1994;125:129-35.

w26 Couch RB. Prevention and treatment of influenza. N Engl J Med 2000;343:1778-87.

w27 Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000;355:827-35.

w28 Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20:127-33.

w29 Friis B, Anderson B, Brenoe E. Antibiotic treatment of pneumonia and bronchiolitis�a prospective randomised study. Arch Dis Child 1984;59:1038-45.

w30 Field CMB, Connolly JH, Murtagh G, Slattery CM, Turkington EE. Antibiotic treatment of epidemic bronchiolitis�a double blind trial. BMJ 1966;i:83-5.

w31 Hruska JF, Morrow PE, Suffin SC, Douglas RG Jr. In vivo inhibition of respiratory syncytial virus by ribavirin. Antimicrob Agents Chemother 1982;21:125-30.

w32 Henderson M, Rubin E. Misuse of antimicrobials in children with asthma and bronchiolitis: a review. Pediatr Infect Dis J 2001;20:214-5.

w33 Kneyber MC, Kimpen JLL. Current concepts on active immunization against respiratory syncytial virus for infants and young children. Pediatr Infect Dis J 2002;21:685-96.

w34 Simoes EA. Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res 2002;3:S26-33.

w35 Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001;20:733-40.